Title : Efficacy and safety of inhaled formoterol 4.5 and 9 μg twice daily in Japanese and European COPD patients: phase III study results.

Pub. Date : 2011 Nov 15

PMID : 22085439






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BACKGROUND: This study evaluated the efficacy and safety of the long-acting beta2-agonist formoterol in patients with moderate-to-severe COPD. Formoterol Fumarate potassium calcium-activated channel subfamily M regulatory beta subunit 2 Homo sapiens